Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Nitrogen containing other than solely as a nitrogen in an...
Reissue Patent
2006-08-01
2006-08-01
Jones, Dwayne (Department: 1614)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Nitrogen containing other than solely as a nitrogen in an...
C514S646000, C514S649000, C514S650000
Reissue Patent
active
RE039221
ABSTRACT:
This invention relates to a composition comprising a tramadol material and acetaminophen, and its use. As used herein tramadol refers to various forms of tramadol. The compositions are pharmacologically useful in treating pain and tussive conditions. The compositions are also subject to less opioid side-effects such as abuse liability, tolerance, constipation and respiratory depression. Furthermore, where the components of the compositions are within certain ratios the pharmacological effects of the compositions are superadditive (synergistic).
REFERENCES:
patent: 2770569 (1956-11-01), Fromherz et al.
patent: 3652589 (1972-03-01), Flick et al.
patent: 3773955 (1973-11-01), Pachter et al.
patent: 3830934 (1974-08-01), Flick et al.
patent: 4132788 (1979-01-01), Wong
patent: 4237140 (1980-12-01), Dudzinski
patent: 4260629 (1981-04-01), Schmidt et al.
patent: 4322427 (1982-03-01), Buyniski et al.
patent: 4571400 (1986-02-01), Arnold
patent: 4601894 (1986-07-01), Hanna et al.
patent: 4631284 (1986-12-01), Salpekar et al.
patent: 4730007 (1988-03-01), Ehrenpreis
patent: 4769372 (1988-09-01), Kreek
patent: 4806543 (1989-02-01), Choi
patent: 4829064 (1989-05-01), Sunshine et al.
patent: 4943565 (1990-07-01), Tencza et al.
patent: 5223541 (1993-06-01), Maryanoff et al.
patent: 5317022 (1994-05-01), Borsodi et al.
patent: 5352680 (1994-10-01), Portoghese et al.
patent: 5468744 (1995-11-01), Raffa et al.
patent: 5516803 (1996-05-01), Raffa
patent: 6562865 (2003-05-01), Codd et al.
patent: 0 017 102 (1980-10-01), None
patent: 0 358 107 (1990-03-01), None
patent: 0 240 904 (1992-07-01), None
patent: 0 358 105 (1994-03-01), None
patent: 0 227 836 (1997-12-01), None
patent: 54-92631 (1979-07-01), None
patent: 55-129225 (1980-10-01), None
patent: 55-154917 (1980-12-01), None
patent: 57-128626 (1982-08-01), None
Budavari, Susan, editor,The Merck Index,11th Edition, Merck & Co., Inc., Rahway, N.J., 1989, pp. 8 and 1506.
In the United States District Court for the District of New Jersey, Civil Action No. 02-2707(JCL),Ortho-McNeil Pharmaceutical, Inc.,v.Kali Laboratories, Inc:.First Amended Complaint for Patent Infringement, Jul. 27, 2005.
In the United States District Court for the District of New Jersey, Civil Action No. 02-2707(JCL),Ortho-McNeil Pharmaceutical, Inc.,v.Kali Laboratories, Inc:.Defendant Kali Laboratories, Inc.'s Second Amended Answer, Counterclaim, and Jury Demand and Defendants Par Pharmaceutical Companies, Inc.'s and Par Pharmaceutical, Inc.'s Answer, Counterclaim, and Jury Demand, Aug. 25, 2005.
In the United States District Court for the District of New Jersey, Civil Action No. 04-886(HAA),Ortho-McNeil Pharmaceutical, Inc.,v.Teva Pharmaceutical Industries Ltd.,Videotape Deposition of Eric Smith, Ph.D., May 13, 2005.
In the United States District Court for the District of New Jersey, Civil Action No. 04-886(HAA),Ortho-McNeil Pharmaceutical, Inc.,v.Teva Pharmaceutical Industries Ltd.,Deposition of Dr. David Schoenfeld, May 17, 2005.
In the United States District Court for the District of New Jersey, Civil Action No. 04-886(HAA),Ortho-McNeil Pharmaceutical, Inc.,v.Teva Pharmaceutical Industries Ltd.,Deposition of Donald Stanski, M.D., May 27, 2005 (REDACTED).
In the United States District Court for the District of New Jersey, Civil Action No. 04-886(HAA),Ortho-McNeil Pharmaceutical, Inc.,v.Teva Pharmaceutical Industries Ltd.,Deposition of Dr. Gilbert Fanciullo, Jun. 14, 2005.
In the United States District Court for the Eastern District of Michigan, Civil Action No. 2:04CV73698,Ortho-McNeil Pharmaceutical, Inc.,v.Caraco Pharmaceutical Laboratories, Ltd.,Caraco's Supplemental Response to Plaintiff's First Set of Interrogatories, Jun. 14, 2005, REDACTED.
In the United States District Court for the Eastern District of Michigan, Civil Action No. 2:04CV73698,Ortho-McNeil Pharmaceutical, Inc.,v.Caraco Pharmaceutical Laboratories, Ltd.,Caraco's Second Supplemental Response to Plaintiff's First Set of Interrogatories, Jun. 24, 2005.
In the United States District Court for the Eastern District of Michigan, Civil Action No. 2:04CV73698,Ortho-McNeil Pharmaceutical, Inc.,v.Caraco Pharmaceutical Laboratories, Ltd.,Caraco's Motion for Summary Judgment of Non-Infringement, Aug. 5, 2005, REDACTED.
In the United States District Court for the Eastern District of Michigan, Civil Action No. 2:04CV73698,Ortho-McNeil Pharmaceutical, Inc.,v.Caraco Pharmaceutical Laboratories, Ltd.,Expert Report of Donald R. Stanski, M.D. Aug. 5, 2005, REDACTED.
In the United States District Court for the Eastern District of Michigan, Civil Action No. 2:04CV73698,Ortho-McNeil Pharmaceutical, Inc.,v.Caraco Pharmaceutical Laboratories, Ltd.,Expert Report of Eric P. Smith, Ph.D., Aug. 8, 2005.
In the United States District Court for the Eastern District of Michigan, Civil Action No. 2:04CV73698,Ortho-McNeil Pharmaceutical, Inc.,v.Caraco Pharmaceutical Laboratories, Ltd.,Ortho-McNeil's Opposition to Caraco's Motion for Summary Judgment of Non-Infringement, Aug. 29, 2005, REDACTED.
In the United States District Court For The District of New Jersey, Civil Action No. 02-5707 (JCL),Ortho-McNeil Pharmaceutical, Inc.v.Kali Laboratories, Inc.:Ortho-McNeil's Brief in Opposition to Kali's Motion for Summary Judgment of Invalidity and Noninfringement of U.S. Pat. No. 5,336,691: Claim 6 (Jul. 21, 2004) [Redacted].
In the United States District Court For The District of New Jersey, Civil Action No. 02-5707 (JCL),Ortho-McNeil Pharmaceutical, Inc.v.Kali Laboratories, Inc.:Ortho-McNeil's Rule 56.1 Statement of Disputed Material Facts in Opposition to Defendant Kali's Laboratories' Motion for Summary Judgment of Invalidity and Noninfringement of U.S. Pat. No. 5,336,691: Claim 6 (Jul. 21, 2004) [Redacted].
In the United States District Court For The District of New Jersey, Civil Action No. 02-5707 (JCL),Ortho-McNeil Pharmaceutical, Inc.v.Kali Laboratories, Inc.:Reply Brief in Support of Defendant Kali Laboratories' Motion for Summary Judgment of Invalidity and Noninfringement of U.S. Pat. No. 5,336,691: Claim 6 (Aug. 23, 2004) [Redacted].
In the United States District Court For The District of New Jersey, Civil Action No. 02-5707 (JCL),Ortho-McNeil Pharmaceutical, Inc.v.Kali Laboratories, Inc.:Ortho-McNeil's Surreply in Opposition to Kali's Motion for Summary Judgment of Invalidity and Noninfringement of U.S. Pat. No. 5,336,691: Claim 6 (Sep. 21, 2004) [Redacted].
In the United States District Court For The District of New Jersey, Civil Action No. 02-5707 (JCL),Ortho-McNeil Pharmaceutical, Inc.v.Kali Laboratories, Inc.:Rule 56.1 Statement of Undisputed Facts for Defendant Kali Laboratories' Motion for Summary Judgment of Invalidity Under the 35 U.S.C. § 102(b) Public Use Bar (May 28, 2004) [Redacted].
In the United States District Court For The District of New Jersey, Civil Action No. 02-5707 (JCL),Ortho-McNeil Pharmaceutical, Inc.v.Kali Laboratories, Inc.:Ortho-McNeil's Brief in Opposition to Kali's Motion for Summary Judgment of Invalidity Under the 35 U.S.C. § 102(b) Public Use Bar (Jul. 21, 2004) [Redacted].
In the United States District Court For The District of New Jersey, Civil Action No. 02-5707 (JCL),Ortho-McNeil Pharmaceutical, Inc.v.Kali Laboratories, Inc.:Ortho-McNeil's Statement of Material Facts in Dispute With Respect to Kali's Motion for Summary Judgment of Invalidity Under the 35 U.S.C. § 102(b) Public Use Bar (Jul. 21, 2004).
In the United States District Court For The District of New Jersey, Civil Action No. 02-5707 (JCL),Ortho-McNeil Pharmaceutical, Inc.v.Kali Laboratories, Inc.:Reply Brief in Support of Defendant Kali Laboratories' Motion for Summary Judgment of Invalidity Under the 35 U.S.C. § 102(b) Public Use Bar (Aug. 23, 2004).
In the United States District Court For The District of New Jersey, Civil Action No. 02-5707 (JCL),Ortho-McNeil Pharmaceutical, Inc.v.Kali Laboratories, Inc.:vol. 1A of Materials Supporting Ortho-McNeil's Oppositions to Kali's Motions for Summary Judgment: Declaration of Jeffrey P. Kushan (Part 1 of 2),with attachments 1 thru 9, Jul. 21, 2004, vol. 1B of Materials
Raffa Robert B.
Vaught Jeffrey L.
Jones Dwayne
Ortho-McNeil Pharmaceutical , Inc.
Woodcock & Washburn LLP
LandOfFree
Composition comprising a tramadol material and acetaminophen... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Composition comprising a tramadol material and acetaminophen..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Composition comprising a tramadol material and acetaminophen... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3627459